Carregant...
Should we screen patients with hematologic malignancies for COVID‐19?
The coronavirus disease (COVID‐19) pandemic has posed several challenges to the hematology community to re‐organize the medical care of patients with hematologic malignancies. Whereas the oncology societies favored a more or less conservative approach which considered the possibility of delaying tre...
Guardat en:
| Publicat a: | Hematol Oncol |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Inc.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7405152/ https://ncbi.nlm.nih.gov/pubmed/32779823 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hon.2780 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|